SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer.

Clinical trial NCT05351788 · RECRUITING

Trial details

NCT number: NCT05351788
Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2022-05-20
Primary completion: 2026-08-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.